POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)
1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_1
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN))		1wb0 CHITOTRIOSIDASE 1
(Homo
sapiens)		4 / 6LEU A 383
PHE A 342
TYR A 267
VAL A 339
None
None
None
IPA  A1393 (-3.6A)
1.08A17.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_1
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN))		2v5y RECEPTOR-TYPE
TYROSINE-PROTEIN
PHOSPHATASE MU
(Homo
sapiens)		4 / 6LEU A 125
TRP A 110
PHE A  79
VAL A 155
None
1.29A16.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_1
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN))		3b8z PROTEIN ADAMTS-5
(Homo
sapiens)		5 / 6LEU A 328
TRP A 344
PHE A 341
TYR A 359
VAL A 396
None
1.49A21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_1
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN))		3ld8 BIFUNCTIONAL
ARGININE DEMETHYLASE
AND
LYSYL-HYDROXYLASE
JMJD6
(Homo
sapiens)		4 / 6LEU A 160
PHE A 294
TYR A 313
VAL A 297
None
None
SO4  A 352 ( 3.8A)
None
1.23A22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_1
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN))		3t6g BREAST CANCER
ANTI-ESTROGEN
RESISTANCE PROTEIN 1
SH2
DOMAIN-CONTAINING
PROTEIN 3C
(Homo
sapiens)		4 / 6HIS B 790
LEU A 623
PHE B 794
VAL B 793
None
1.17A21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_1
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN))		4kf6 GLYCOLIPID TRANSFER
PROTEIN
DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens)		4 / 6HIS A 150
LEU A 146
TRP A 117
VAL A 154
1T9  A 301 (-4.5A)
1T9  A 301 (-4.6A)
1T9  A 301 (-4.0A)
1T9  A 301 ( 4.1A)
1.13A22.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_1
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN))		4nn0 COMPLEMENT C1Q TUMOR
NECROSIS
FACTOR-RELATED
PROTEIN 5
(Homo
sapiens)		4 / 6LEU A 168
PHE A 153
TYR A 136
VAL A 197
None
1.23A20.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_1
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN))		5fn4 NICASTRIN
(Homo
sapiens)		4 / 6HIS A 553
LEU A 551
PHE A 525
VAL A 299
None
1.34A15.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_1
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN))		5l3q SIGNAL RECOGNITION
PARTICLE RECEPTOR
SUBUNIT ALPHA
(Homo
sapiens)		4 / 6LEU B 623
TRP B 441
PHE B 613
VAL B 586
None
1.28A15.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_1
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN))		5oom 39S RIBOSOMAL
PROTEIN L39,
MITOCHONDRIAL
(Homo
sapiens)		4 / 6LEU 7 189
TRP 7 192
PHE 7 158
VAL 7 164
None
1.29A22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_2
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN)
IGG2B-KAPPA 40-50
FAB (LIGHT CHAIN))		1evs ONCOSTATIN M
(Homo
sapiens)		4 / 7HIS A 178
SER A 179
ARG A 182
LEU A  62
None
1.16A19.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_2
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN)
IGG2B-KAPPA 40-50
FAB (LIGHT CHAIN))		2ctr DNAJ HOMOLOG
SUBFAMILY B MEMBER 9
(Homo
sapiens)		4 / 7THR A  77
SER A  78
TYR A  10
LEU A  59
None
1.13A15.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_2
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN)
IGG2B-KAPPA 40-50
FAB (LIGHT CHAIN))		2gl7 B-CELL LYMPHOMA 9
PROTEIN
(Homo
sapiens)		4 / 7SER C 352
SER C 362
ARG C 359
LEU C 366
None
1.17A12.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_2
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN)
IGG2B-KAPPA 40-50
FAB (LIGHT CHAIN))		2n8a POLY [ADP-RIBOSE]
POLYMERASE 1
(Homo
sapiens)		4 / 7SER A   4
ARG A  10
TYR A  13
LEU A  33
None
0.99A22.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_2
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN)
IGG2B-KAPPA 40-50
FAB (LIGHT CHAIN))		2okj GLUTAMATE
DECARBOXYLASE 1
(Homo
sapiens)		4 / 7THR A 136
SER A 135
ARG A 181
TYR A 178
None
1.12A18.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_2
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN)
IGG2B-KAPPA 40-50
FAB (LIGHT CHAIN))		2ziu CROSSOVER JUNCTION
ENDONUCLEASE EME1
MUS81 PROTEIN
(Danio
rerio;
Homo
sapiens)		4 / 7THR A 560
SER A 559
TYR B 514
LEU B 510
None
1.06A22.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_2
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN)
IGG2B-KAPPA 40-50
FAB (LIGHT CHAIN))		3g2f BONE MORPHOGENETIC
PROTEIN RECEPTOR
TYPE-2
(Homo
sapiens)		4 / 7SER A 428
ARG A 419
TYR A 290
LEU A 304
None
0.99A19.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_2
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN)
IGG2B-KAPPA 40-50
FAB (LIGHT CHAIN))		3q6z POLY [ADP-RIBOSE]
POLYMERASE 14
(Homo
sapiens)		4 / 7SER A 838
HIS A 879
TYR A 911
LEU A 907
None
0.99A21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_2
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN)
IGG2B-KAPPA 40-50
FAB (LIGHT CHAIN))		4giw RUN AND SH3
DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens)		4 / 7THR A  97
SER A  99
SER A  90
LEU A 146
None
1.04A22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_2
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN)
IGG2B-KAPPA 40-50
FAB (LIGHT CHAIN))		4l87 SERINE--TRNA LIGASE,
CYTOPLASMIC
(Homo
sapiens)		4 / 7SER A 374
SER A 330
TYR A 410
LEU A 290
None
1.13A20.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_2
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN)
IGG2B-KAPPA 40-50
FAB (LIGHT CHAIN))		4xnv P2Y PURINOCEPTOR 1,
RUBREDOXIN, P2Y
PURINOCEPTOR 1
(Clostridium
pasteurianum;
Homo
sapiens)		4 / 7SER A  87
HIS A 148
SER A 151
ARG A 149
None
Y01  A1104 (-3.8A)
Y01  A1104 ( 3.9A)
None
1.08A19.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1IBG_H_OBNH1_2
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN)
IGG2B-KAPPA 40-50
FAB (LIGHT CHAIN))		5b8c PEMBROLIZUMAB LIGHT
CHAIN VARIABLE
REGION (PEMVL)
(Homo
sapiens)		5 / 7THR A  31
SER A  32
SER A  95
ARG A  96
LEU A 100
None
0.66A42.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_2
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN)
IGG2B-KAPPA 40-50
FAB (LIGHT CHAIN))		5whr INDOLEAMINE
2,3-DIOXYGENASE 1
(Homo
sapiens)		5 / 7THR A 395
SER A 398
SER A 341
ARG A 343
LEU A 211
None
None
None
HEM  A 501 (-3.9A)
None
1.44A16.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_2
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN)
IGG2B-KAPPA 40-50
FAB (LIGHT CHAIN))		5whr INDOLEAMINE
2,3-DIOXYGENASE 1
(Homo
sapiens)		4 / 7THR A 395
SER A 398
SER A 344
ARG A 343
None
None
None
HEM  A 501 (-3.9A)
1.17A16.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_2
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN)
IGG2B-KAPPA 40-50
FAB (LIGHT CHAIN))		5wiv D(4) DOPAMINE
RECEPTOR, SOLUBLE
CYTOCHROME B562
CHIMERA
(Escherichia
coli;
Homo
sapiens)		4 / 7SER A  71
SER A 130
ARG A 133
LEU A 211
OLA  A1207 (-3.2A)
None
PO4  A1205 (-2.5A)
None
1.13A19.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_2
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN)
IGG2B-KAPPA 40-50
FAB (LIGHT CHAIN))		5y3r DNA-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
(Homo
sapiens)		4 / 7THR C 481
SER C 480
TYR C 565
LEU C 564
None
1.13A4.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IBG_H_OBNH1_2
(IGG2B-KAPPA 40-50
FAB (HEAVY CHAIN)
IGG2B-KAPPA 40-50
FAB (LIGHT CHAIN))		6cvz E3 UBIQUITIN-PROTEIN
LIGASE RFWD3
(Homo
sapiens)		4 / 7THR A 662
SER A 665
ARG A 664
LEU A 651
None
1.11A17.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A3Y_A_OBNA6000_1
(NA, K-ATPASE ALPHA
SUBUNIT)		1i51 CASPASE-7 SUBUNIT
P20
(Homo
sapiens)		5 / 10PHE A 182
ALA A  96
PHE A 101
PHE A 106
LEU A 104
None
1.33A9.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A3Y_A_OBNA6000_1
(NA, K-ATPASE ALPHA
SUBUNIT)		1k86 CASPASE-7
(Homo
sapiens)		5 / 10PHE A 182
ALA A  96
PHE A 101
PHE A 106
LEU A 104
None
1.37A12.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A3Y_A_OBNA6000_1
(NA, K-ATPASE ALPHA
SUBUNIT)		2aw5 NADP-DEPENDENT MALIC
ENZYME
(Homo
sapiens)		5 / 10GLU A  95
GLY A 433
ALA A 405
LEU A 499
ARG A 498
None
1.35A20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A3Y_A_OBNA6000_1
(NA, K-ATPASE ALPHA
SUBUNIT)		2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2
(Homo
sapiens)		5 / 10PHE A  80
VAL A  38
ALA A  41
LEU A 268
THR A  23
None
None
None
NAP  A   1 (-4.2A)
None
1.17A15.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A3Y_A_OBNA6000_1
(NA, K-ATPASE ALPHA
SUBUNIT)		2ql7 CASPASE-7
(Homo
sapiens)		5 / 10PHE A 182
ALA A  96
PHE A 101
PHE A 106
LEU A 104
None
1.37A10.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A3Y_A_OBNA6000_1
(NA, K-ATPASE ALPHA
SUBUNIT)		4cak INTEGRIN ALPHA-IIB
INTEGRIN BETA-3
(Homo
sapiens)		5 / 10PHE B 223
GLY A 354
VAL B 231
PHE B 248
LEU B 117
None
1.40A20.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A3Y_A_OBNA6000_1
(NA, K-ATPASE ALPHA
SUBUNIT)		4cns DIHYDROPYRIMIDINASE-
LIKE 3
(Homo
sapiens)		5 / 10GLU A 435
GLY A 357
ALA A 332
PHE A 301
LEU A 307
None
None
MG  A1495 ( 3.9A)
None
None
1.21A19.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A3Y_A_OBNA6000_1
(NA, K-ATPASE ALPHA
SUBUNIT)		4cnt DIHYDROPYRIMIDINASE-
LIKE 3
(Homo
sapiens)		5 / 10GLU A 435
GLY A 357
ALA A 332
PHE A 301
LEU A 307
None
1.20A20.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A3Y_A_OBNA6000_1
(NA, K-ATPASE ALPHA
SUBUNIT)		4fdh CYTOCHROME P450
11B2, MITOCHONDRIAL
(Homo
sapiens)		5 / 10GLY A 314
ALA A 456
PHE A 321
THR A 196
ARG A 490
0T3  A 602 ( 3.3A)
HEM  A 601 ( 3.8A)
None
None
None
1.33A18.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A3Y_A_OBNA6000_1
(NA, K-ATPASE ALPHA
SUBUNIT)		4u0z ADENOSINE
MONOPHOSPHATE-PROTEI
N TRANSFERASE FICD
(Homo
sapiens)		5 / 10GLU A 328
PHE A 309
GLY A 307
PHE A 365
LEU A 359
None
1.38A17.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A3Y_A_OBNA6000_1
(NA, K-ATPASE ALPHA
SUBUNIT)		4ued EUKARYOTIC
TRANSLATION
INITIATION FACTOR 4E
(Homo
sapiens)		5 / 10GLU A 132
GLY A 180
VAL A 176
ALA A 175
PHE A 142
None
1.14A10.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A3Y_A_OBNA6000_1
(NA, K-ATPASE ALPHA
SUBUNIT)		4ued EUKARYOTIC
TRANSLATION
INITIATION FACTOR 4E
(Homo
sapiens)		5 / 10GLU A 132
GLY A 180
VAL A 176
PHE A 142
THR A 167
None
1.08A10.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A3Y_A_OBNA6000_1
(NA, K-ATPASE ALPHA
SUBUNIT)		4wlp UBIQUITIN
CARBOXYL-TERMINAL
HYDROLASE ISOZYME L5
(Homo
sapiens)		5 / 10GLY A  51
VAL A 224
PHE A  54
LEU A 220
ARG A 207
None
1.32A15.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A3Y_A_OBNA6000_1
(NA, K-ATPASE ALPHA
SUBUNIT)		4zvs CASPASE-7
(Homo
sapiens)		5 / 10PHE A 182
ALA A  96
PHE A 101
PHE A 106
LEU A 104
None
1.37A10.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A3Y_A_OBNA6000_1
(NA, K-ATPASE ALPHA
SUBUNIT)		5ei3 EUKARYOTIC
TRANSLATION
INITIATION FACTOR 4E
(Homo
sapiens)		5 / 10GLU A 132
GLY A 180
VAL A 176
ALA A 175
PHE A 142
None
1.12A11.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A3Y_A_OBNA6000_1
(NA, K-ATPASE ALPHA
SUBUNIT)		5ei3 EUKARYOTIC
TRANSLATION
INITIATION FACTOR 4E
(Homo
sapiens)		5 / 10GLU A 132
GLY A 180
VAL A 176
PHE A 142
THR A 167
None
1.07A11.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A3Y_A_OBNA6000_1
(NA, K-ATPASE ALPHA
SUBUNIT)		5fd3 PROTEIN LIN-54
HOMOLOG
(Homo
sapiens)		5 / 10PHE A 540
GLY A 543
PHE A 579
LEU A 572
ARG A 574
None
1.32A9.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A3Y_A_OBNA6000_1
(NA, K-ATPASE ALPHA
SUBUNIT)		5jpn COMPLEMENT C4-A
(Homo
sapiens)		5 / 10GLY B 998
VAL B1000
ALA B1001
THR B1021
ARG A 187
None
1.27A21.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_A_OBNA1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		1cm8 PHOSPHORYLATED MAP
KINASE P38-GAMMA
(Homo
sapiens)		5 / 11PRO A 353
ASP A  91
VAL A  53
ALA A  44
ILE A  55
None
1.39A16.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_A_OBNA1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		1gng FRATTIDE
GLYCOGEN SYNTHASE
KINASE-3 BETA
(Homo
sapiens)		5 / 11VAL X 217
ALA X 216
PHE A 257
THR A 275
ILE X 213
None
1.27A3.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_A_OBNA1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		1soj CGMP-INHIBITED
3',5'-CYCLIC
PHOSPHODIESTERASE B
(Homo
sapiens)		5 / 11VAL A 685
PHE A 679
THR A 743
ILE A 740
ARG A 755
None
1.36A19.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_A_OBNA1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		2wkp NPH1-1, RAS-RELATED
C3 BOTULINUM TOXIN
SUBSTRATE 1
(Avena
sativa;
Homo
sapiens)		5 / 11ASP A 471
ASN A 472
VAL A 476
PHE A 509
ILE A 466
None
None
None
None
FMN  A1725 (-4.2A)
1.14A16.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_A_OBNA1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		2wkp NPH1-1, RAS-RELATED
C3 BOTULINUM TOXIN
SUBSTRATE 1
(Avena
sativa;
Homo
sapiens)		5 / 11ASP A 471
VAL A 476
PHE A 509
ILE A 466
ARG A 421
None
None
None
FMN  A1725 (-4.2A)
None
1.03A16.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_A_OBNA1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		2ypd PROBABLE JMJC
DOMAIN-CONTAINING
HISTONE
DEMETHYLATION PROT
EIN 2C
(Homo
sapiens)		5 / 11GLN A2476
ASN A2470
VAL A2323
PHE A2367
ARG A2379
EMT  A3503 (-4.8A)
None
None
None
None
1.33A16.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_A_OBNA1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		5fzo PROBABLE JMJC
DOMAIN-CONTAINING
HISTONE
DEMETHYLATION PROT
EIN 2C
(Homo
sapiens)		5 / 11GLN A2476
ASN A2470
VAL A2323
PHE A2367
ARG A2379
None
1.36A15.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_A_OBNA1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		5hzh RAS-RELATED C3
BOTULINUM TOXIN
SUBSTRATE
1,NPH1-1,RAS-RELATED
C3 BOTULINUM TOXIN
SUBSTRATE 1
(Avena
sativa;
Homo
sapiens)		5 / 11ASP A 118
ASN A 119
VAL A 123
PHE A 156
ILE A 113
None
None
None
FMN  A 402 (-4.9A)
FMN  A 402 (-4.3A)
1.20A16.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_A_OBNA1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		5hzh RAS-RELATED C3
BOTULINUM TOXIN
SUBSTRATE
1,NPH1-1,RAS-RELATED
C3 BOTULINUM TOXIN
SUBSTRATE 1
(Avena
sativa;
Homo
sapiens)		5 / 11ASP A 118
VAL A 123
PHE A 156
ILE A 113
ARG A  68
None
None
FMN  A 402 (-4.9A)
FMN  A 402 (-4.3A)
None
1.35A16.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_A_OBNA1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		5hzk INTERSECTIN-1,NPH1-1
,INTERSECTIN-1
(Avena
sativa;
Homo
sapiens)		5 / 11ASP B1376
ASN B1377
VAL B1381
PHE B1414
ILE B1371
None
None
None
FMN  B1801 (-4.8A)
FMN  B1801 (-4.1A)
1.25A21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_A_OBNA1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		5hzk INTERSECTIN-1,NPH1-1
,INTERSECTIN-1
(Avena
sativa;
Homo
sapiens)		5 / 11ASP B1376
VAL B1381
PHE B1414
ILE B1371
ARG B1326
None
None
FMN  B1801 (-4.8A)
FMN  B1801 (-4.1A)
None
1.31A21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_A_OBNA1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		6b0t FASCIN
(Homo
sapiens)		5 / 11ASP A 192
ALA A 153
THR A 190
ILE A 177
ARG A 197
None
1.28A6.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_C_OBNC1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		1o8r GUANYLIN
(Homo
sapiens)		5 / 11GLN A  71
PRO A  39
LEU A  12
VAL A   3
ALA A  90
None
1.18A7.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_C_OBNC1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		2buj SERINE/THREONINE-PRO
TEIN KINASE 16
(Homo
sapiens)		5 / 11ASP A 148
ASN A 153
LEU A 149
VAL A 224
PHE A 239
None
1.29A15.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_C_OBNC1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		2v70 SLIT HOMOLOG 2
PROTEIN N-PRODUCT
(Homo
sapiens)		5 / 11GLN A 641
PRO A 665
ASN A 664
LEU A 661
ALA A 649
None
1.42A12.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_C_OBNC1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		2ypd PROBABLE JMJC
DOMAIN-CONTAINING
HISTONE
DEMETHYLATION PROT
EIN 2C
(Homo
sapiens)		5 / 11GLN A2476
ASN A2470
VAL A2323
PHE A2367
ARG A2379
EMT  A3503 (-4.8A)
None
None
None
None
1.33A16.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_C_OBNC1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		3njp EPIDERMAL GROWTH
FACTOR RECEPTOR
(Homo
sapiens)		5 / 11GLN A 184
LEU A  80
VAL A  65
PHE A 126
PHE A 156
None
1.40A19.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_C_OBNC1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		3pgl CARBOXY-TERMINAL
DOMAIN RNA
POLYMERASE II
POLYPEPTIDE A SMALL
PHOSPHATASE 1
(Homo
sapiens)		5 / 11PRO A 209
ASP A 206
LEU A 205
PHE A 226
THR A 100
None
MG  A   1 ( 4.4A)
None
None
None
1.42A10.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_C_OBNC1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		4awn DEOXYRIBONUCLEASE-1
(Homo
sapiens)		5 / 11LEU A 195
VAL A 225
ALA A 224
PHE A 128
PHE A 118
None
1.34A14.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_C_OBNC1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		4f52 CULLIN-1
E3 UBIQUITIN-PROTEIN
LIGASE RBX1
(Homo
sapiens)		5 / 11LEU A 540
VAL B  30
ALA B  29
PHE A 566
PHE A 569
None
1.43A15.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_C_OBNC1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		4qci ANTI-PDGF-BB
ANTIBODY - LIGHT
CHAIN
(Homo
sapiens)		5 / 11ASP A  81
LEU A 103
VAL A  12
ALA A  13
THR A  77
None
1.38A12.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_C_OBNC1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		5fzo PROBABLE JMJC
DOMAIN-CONTAINING
HISTONE
DEMETHYLATION PROT
EIN 2C
(Homo
sapiens)		5 / 11GLN A2476
ASN A2470
VAL A2323
PHE A2367
ARG A2379
None
1.36A15.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_C_OBNC1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		5o2d POLY [ADP-RIBOSE]
POLYMERASE 14
(Homo
sapiens)		5 / 11LEU A1077
VAL A1069
ALA A1070
THR A1075
ARG A1098
None
1.13A11.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_C_OBNC1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		5yc1 TNF
RECEPTOR-ASSOCIATED
FACTOR 4
(Homo
sapiens)		5 / 11PRO A 401
ASP A 392
LEU A 390
VAL A 456
ALA A 455
None
1.14A11.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_A_OBNA1104_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		1he7 HIGH AFFINITY NERVE
GROWTH FACTOR
RECEPTOR
(Homo
sapiens)		5 / 12GLY A 357
ALA A 376
PHE A 317
LEU A 322
ILE A 301
None
1.21A7.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_A_OBNA1104_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		1ij9 VASCULAR CELL
ADHESION PROTEIN 1
(Homo
sapiens)		5 / 12LEU A 128
GLU A 163
GLY A 131
LEU A 103
ILE A  97
None
1.20A11.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_A_OBNA1104_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		1zjk MANNAN-BINDING
LECTIN SERINE
PROTEASE 2
(Homo
sapiens)		5 / 12LEU A 575
GLY A 635
ALA A 469
PHE A 456
ARG A 439
None
1.16A18.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_A_OBNA1104_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		2l08 REGULATOR OF
NONSENSE TRANSCRIPTS
3A
(Homo
sapiens)		5 / 12LEU A  26
ALA A  88
PHE A  73
PHE A  69
LEU A  33
None
1.03A7.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_A_OBNA1104_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		3fgq NEUROSERPIN
(Homo
sapiens)		5 / 12GLU A 122
GLY A 324
ALA A  64
LEU A 112
ILE A 315
None
1.21A17.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_A_OBNA1104_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		3nvn PLEXIN-C1
(Homo
sapiens)		5 / 12LEU B  72
GLY B  56
PHE B  58
LEU B  65
ILE B  49
None
1.02A20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_A_OBNA1104_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		5c16 MYOTUBULARIN-RELATED
PROTEIN 1
(Homo
sapiens)		5 / 12GLU A 467
ALA A 446
PHE A 541
LEU A 533
ILE A 500
None
1.10A20.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_A_OBNA1104_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		5jho ELECTRONEUTRAL
SODIUM BICARBONATE
EXCHANGER 1
(Homo
sapiens)		5 / 12LEU A 108
GLY A 304
ALA A 308
PHE A 288
LEU A 120
None
1.10A17.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		1uzj FIBRILLIN-1
(Homo
sapiens)		4 / 5ASP A1537
ASN A1551
ILE A1553
VAL A1645
None
1.18A9.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		2bo9 HUMAN LATEXIN
(Homo
sapiens)		4 / 5PRO B  99
ASP B 103
ILE B  62
VAL B 142
None
None
MPD  B 303 ( 4.8A)
None
1.35A11.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		2eyy V-CRK SARCOMA VIRUS
CT10 ONCOGENE
HOMOLOG ISOFORM A
(Homo
sapiens)		4 / 5PRO A 165
ASP A 163
ASN A 171
ILE A 182
None
1.42A11.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		2v5t NEURAL CELL ADHESION
MOLECULE 2
(Homo
sapiens)		4 / 5PRO A 209
ASP A 290
ILE A 242
VAL A 280
None
1.24A13.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		2wim NEURAL CELL ADHESION
MOLECULE 2
(Homo
sapiens)		4 / 5PRO A 209
ASP A 290
ILE A 242
VAL A 280
None
1.25A15.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		2xy1 NEURAL CELL ADHESION
MOLECULE 2
(Homo
sapiens)		4 / 5PRO A 209
ASP A 290
ILE A 242
VAL A 280
None
1.22A12.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		3d3k ENHANCER OF
MRNA-DECAPPING
PROTEIN 3
(Homo
sapiens)		4 / 5PRO A 444
ASP A 443
ILE A 474
VAL A 502
None
1.02A13.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		3e4e CYTOCHROME P450 2E1
(Homo
sapiens)		4 / 5PRO A 365
ASP A 394
ILE A  53
VAL A  79
None
1.32A18.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		3fjo NADPH-CYTOCHROME
P450 REDUCTASE
(Homo
sapiens;
Saccharomyces
cerevisiae)		4 / 5PRO A 429
ASP A 356
ILE A 407
VAL A 311
None
1.21A20.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		3g4e REGUCALCIN
(Homo
sapiens)		4 / 5PRO A 229
ASP A 228
ILE A 208
VAL A 289
None
1.45A14.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		3qfs NADPH--CYTOCHROME
P450 REDUCTASE
(Homo
sapiens)		4 / 5PRO A 452
ASP A 379
ILE A 430
VAL A 334
None
1.32A17.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		4obs ALPHA-L-IDURONIDASE
(Homo
sapiens)		4 / 5ASP A 349
ASN A 350
ILE A  85
VAL A 322
None
1.27A20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		5lwe C-C CHEMOKINE
RECEPTOR TYPE 9
(Homo
sapiens)		4 / 5ASP A  94
ASN A 313
ILE A 137
VAL A 262
None
None
None
OLA  A 402 ( 4.0A)
1.26A15.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		5t1a CHIMERA PROTEIN OF
CC CHEMOKINE
RECEPTOR TYPE 2
ISOFORM B AND
T4-LYSOZYME,LYSOZYME
(Escherichia
virus
T4;
Homo
sapiens)		4 / 5ASP A  88
ASN A 301
ILE A 131
VAL A 251
None
1.25A20.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		5uiw C-C CHEMOKINE
RECEPTOR TYPE
5,RUBREDOXIN CHIMERA
(Clostridium
pasteurianum;
Homo
sapiens)		4 / 5ASP A  76
ASN A 293
ILE A 119
VAL A 243
None
1.33A18.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		5vgz 26S PROTEASOME
REGULATORY SUBUNIT 4
(Homo
sapiens)		4 / 5PRO B 106
ASN B 153
ILE B 160
VAL B 133
None
1.30A8.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_C_OBNC2004_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		1he7 HIGH AFFINITY NERVE
GROWTH FACTOR
RECEPTOR
(Homo
sapiens)		5 / 12GLY A 357
ALA A 376
PHE A 317
LEU A 322
ILE A 301
None
1.21A7.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_C_OBNC2004_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		1ij9 VASCULAR CELL
ADHESION PROTEIN 1
(Homo
sapiens)		5 / 12LEU A 128
GLU A 163
GLY A 131
LEU A 103
ILE A  97
None
1.20A11.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_C_OBNC2004_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		1zjk MANNAN-BINDING
LECTIN SERINE
PROTEASE 2
(Homo
sapiens)		5 / 12LEU A 575
GLY A 635
ALA A 469
PHE A 456
ARG A 439
None
1.17A18.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_C_OBNC2004_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		2l08 REGULATOR OF
NONSENSE TRANSCRIPTS
3A
(Homo
sapiens)		5 / 12LEU A  26
ALA A  88
PHE A  73
PHE A  69
LEU A  33
None
1.03A7.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_C_OBNC2004_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		3nvn PLEXIN-C1
(Homo
sapiens)		5 / 12LEU B  72
GLY B  56
PHE B  58
LEU B  65
ILE B  49
None
1.02A20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_C_OBNC2004_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		5c16 MYOTUBULARIN-RELATED
PROTEIN 1
(Homo
sapiens)		5 / 12GLU A 467
ALA A 446
PHE A 541
LEU A 533
ILE A 500
None
1.10A20.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_C_OBNC2004_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		5jho ELECTRONEUTRAL
SODIUM BICARBONATE
EXCHANGER 1
(Homo
sapiens)		5 / 12LEU A 108
GLY A 304
ALA A 308
PHE A 288
LEU A 120
None
1.08A17.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_C_OBNC2004_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		5vfr PROTEASOME SUBUNIT
ALPHA TYPE-2
(Homo
sapiens)		5 / 12LEU H  26
GLU H 120
GLY H 153
LEU H  86
ARG H  89
None
1.17Aundetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_C_OBNC2004_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		2eyy V-CRK SARCOMA VIRUS
CT10 ONCOGENE
HOMOLOG ISOFORM A
(Homo
sapiens)		4 / 4PRO A 165
ASP A 163
ASN A 171
ILE A 182
None
1.42A11.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XE5_A_OBNA1104_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		2iwz 3-OXOACYL-[ACYL-CARR
IER-PROTEIN]
SYNTHASE
(Homo
sapiens)		5 / 12GLN A 430
LEU A 422
GLU A 431
ALA A 373
PHE A 438
None
1.24A18.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XE5_A_OBNA1104_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		2lv7 CALCIUM-BINDING
PROTEIN 7
(Homo
sapiens)		5 / 12GLU A  92
GLU A  93
LEU A  98
ALA A  41
ASP A  86
None
CA  A 202 (-2.4A)
None
None
CA  A 202 (-3.2A)
1.29A6.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XE5_A_OBNA1104_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		2owi REGULATOR OF
G-PROTEIN SIGNALING
18
(Homo
sapiens)		5 / 12GLU A  13
LEU A 129
GLY A  24
ALA A  27
ILE A 125
None
1.26A9.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XE5_A_OBNA1104_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		3dlj BETA-ALA-HIS
DIPEPTIDASE
(Homo
sapiens)		5 / 12GLU A 451
GLY A 142
ALA A 146
ILE A 464
ASP A 448
None
1.17A20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XE5_A_OBNA1104_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		3l6r SERINE RACEMASE
(Homo
sapiens)		5 / 12GLU A 283
GLU A  47
GLY A 289
ALA A 292
GLU A 266
LLP  A  56 ( 3.6A)
None
None
None
None
1.28A17.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XE5_A_OBNA1104_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		5vhj 26S PROTEASOME
REGULATORY SUBUNIT 7
(Homo
sapiens)		5 / 12ASP A 325
LEU A 327
GLU A 276
GLY A 281
ALA A 283
None
1.24A13.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XE5_A_OBNA1104_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		5xtd NADH DEHYDROGENASE
[UBIQUINONE] 1 ALPHA
SUBCOMPLEX SUBUNIT
10, MITOCHONDRIAL
(Homo
sapiens)		5 / 12ASP w  63
GLY w  71
ALA w  74
ILE w  60
ASP w 166
None
1.07A15.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XE5_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		2g9n EUKARYOTIC
INITIATION FACTOR
4A-I
(Homo
sapiens)		4 / 6PRO A  55
ILE A  30
VAL A 236
THR A  85
MLY  A  54 ( 2.6A)
None
MLY  A 237 ( 3.0A)
MLY  A  82 ( 3.9A)
1.09A11.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XE5_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		2h18 ADP-RIBOSYLATION
FACTOR-LIKE PROTEIN
8A
(Homo
sapiens)		4 / 6ILE A  67
VAL A  39
PHE A  16
THR A 173
None
1.08A10.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XE5_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		2jvn POLY [ADP-RIBOSE]
POLYMERASE 1
(Homo
sapiens)		4 / 6ILE A 248
VAL A 255
THR A 335
ARG A 282
None
0.81A8.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XE5_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		2nmp CYSTATHIONINE
GAMMA-LYASE
(Homo
sapiens)		4 / 6PRO A 198
ILE A 167
VAL A 176
ARG A 305
None
1.12A18.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XE5_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		3fbk REGULATOR OF
G-PROTEIN SIGNALING
3
(Homo
sapiens)		4 / 6PRO A  95
ILE A 131
VAL A 116
THR A  86
None
0.89A9.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XE5_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		3jxf RECEPTOR-TYPE
TYROSINE-PROTEIN
PHOSPHATASE ZETA
(Homo
sapiens)		4 / 6ILE A 196
VAL A 203
PHE A 263
THR A 101
None
0.75A13.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XE5_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		3qvu SULFOTRANSFERASE 1A1
(Homo
sapiens)		4 / 6PRO A  74
ILE A 243
PHE A  84
THR A  95
None
1.12A13.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XE5_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		3v6a APOPTOSIS INHIBITOR
5
(Homo
sapiens)		4 / 6ILE A 197
VAL A 171
PHE A 137
ARG A 148
None
1.09A18.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XE5_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		3v6a APOPTOSIS INHIBITOR
5
(Homo
sapiens)		4 / 6ILE A 197
VAL A 171
PHE A 137
THR A 132
None
1.13A18.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XE5_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		4uuu CYSTATHIONINE
BETA-SYNTHASE
(Homo
sapiens)		4 / 6PRO A 422
ILE A 455
VAL A 459
PHE A 487
SAM  A1546 (-4.7A)
None
None
None
1.04A9.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XE5_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		4v11 SYNAPTOTAGMIN-1
(Homo
sapiens)		4 / 6PRO A 338
ILE A 374
VAL A 360
THR A 329
None
0.83A9.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XE5_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		5ixd TYROSINE-PROTEIN
KINASE JAK1
(Homo
sapiens)		4 / 6ILE A 384
VAL A 381
PHE A 405
THR A 288
None
1.18A20.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XE5_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		5mr7 GRAINYHEAD-LIKE
PROTEIN 2 HOMOLOG
(Homo
sapiens)		4 / 6ILE A 393
PHE A 357
THR A 343
ARG A 297
None
1.07A7.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XE5_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		6chd LYSINE--TRNA LIGASE
(Homo
sapiens)		4 / 6ILE A 353
PHE A 486
THR A 500
ARG A 393
None
1.17A6.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XE5_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		6d6q EXOSOME COMPLEX
EXONUCLEASE RRP44
(Homo
sapiens)		4 / 6PRO K 375
ILE K 402
VAL K 417
ARG K 384
 A  O  51 ( 4.5A)
None
None
A  O  48 ( 3.6A)
1.13A4.80